EMILY C. LEONGINI is a Partner in the Los Angeles office of ArentFox Schiff LLP. Emily provides strategic regulatory counsel to companies in FDA-regulated industries, helping clients understand and mitigate risk as they develop and launch new products, manage commercial relationships, navigate post-market regulatory requirements, and respond to regulatory actions and potential crises. Since joining ArentFox Schiff from FDA, where she worked for six years, Emily has helped companies of all sizes navigate legal and regulatory requirements implemented and enforced by FDA, USDA, FTC, and DEA, and their state counterparts. She advises clients at every stage of the product lifecycle and has extensive experience with dietary supplement good manufacturing practice requirements, dietary ingredient/formulation reviews, and assessing proposed advertising and labeling claims for dietary supplement products. In addition to her work with conventional food and dietary supplement clients, Emily also counsels cannabis/hemp/CBD companies on a wide array of state and federal matters. She is a frequent presenter at related regulatory and industry conferences, and her legal analyses have been published in Law360 and Los Angeles Business Journal.